The Patent Finder
AC

Actualeyes Inc.

First filing 2014
OverviewNotableFeesChangesFamiliesPatent listSources & methods

One patent currently held, every record listed here

2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Apr 2036. from the record

Of the 2 now held by other companies, 2 name Aurion Biotech Inc. as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Apr 2036
Next term end
1
Patent families

When these terms end

Each bar runs from grant to computed term end. 2021 to 2036.
US 11,624,053 Application of Laminin to Corneal Endothelial Cell Culture Nov 26, 2034
US 10,908,161 Corneal Endothelial Cell Marker Apr 9, 2036
US 12,072,334 Corneal Endothelial Cell Marker Apr 9, 2036
20242027203020332036
4 pending applications: term is not computable until grant.Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
Cited by 3 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2034.
Ends Nov 2034 · High confidence
Also notable
Granted 2021. Computed term ends 2036.
Ends Apr 2036 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 17, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
Corneal Endothelial Cell Marker1 in forceto Apr 2036

Patents held now

Soonest term end first.

Showing 1 to 1 of 1

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 12,072,334Corneal Endothelial Cell Marker
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 1: 2 patents in force now held by others · 4 applications pending · 2 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited